Home › Brain Diseases › Minnesota
Brain Diseases clinical trials in Minnesota
3 studies for Brain Diseases are looking for participants at sites in Minnesota.
Cities in Minnesota
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- Struthers Parkinson's Center, Golden Valley
- Mayo Clinic in Rochester, Minnesota, Rochester
RecruitingPhase 2
Ages 55 to 85 · All sexes · Updated Sep 22, 2026 · NCT07589595Automating Delirium Severity in the ICU
- Mayo Clinic, Rochester
RecruitingObservational study
Ages 50 and older · All sexes · Updated Apr 8, 2026 · NCT06172491North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)
- Mayo Clinic, Rochester
RecruitingObservational studyHealthy volunteers welcome
All ages · All sexes · Updated Feb 4, 2026 · NCT01694940From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.